Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Net Income Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual net income in 2023 was -260 Million USD , down -1833.33% from previous year.
  • Bausch + Lomb Corporation's latest quarterly net income in 2024 Q3 was -124 Million USD , up 17.88% from previous quarter.
  • Bausch + Lomb Corporation reported an annual net income of 15 Million USD in 2022, down -91.76% from previous year.
  • Bausch + Lomb Corporation reported an annual net income of 182 Million USD in 2021, up 1170.59% from previous year.
  • Bausch + Lomb Corporation reported a quarterly net income of -167 Million USD for 2024 Q1, down -209.26% from previous quarter.
  • Bausch + Lomb Corporation reported a quarterly net income of -151 Million USD for 2024 Q2, up 9.58% from previous quarter.

Annual Net Income Chart of Bausch + Lomb Corporation (2023 - 2018)

Historical Annual Net Income of Bausch + Lomb Corporation (2023 - 2018)

Year Net Income Net Income Growth
2023 -260 Million USD -1833.33%
2022 15 Million USD -91.76%
2021 182 Million USD 1170.59%
2020 -17 Million USD -105.7%
2019 298 Million USD -58.03%
2018 710 Million USD 0.0%

Peer Net Income Comparison of Bausch + Lomb Corporation

Name Net Income Net Income Difference
Alcon Inc. 974 Million USD 126.694%
AptarGroup, Inc. 284.48 Million USD 191.393%
Baxter International Inc. 2.65 Billion USD 109.789%
Becton, Dickinson and Company 1.72 Billion USD 115.064%
Haemonetics Corporation 117.55 Million USD 321.167%
Envista Holdings Corp -100.2 Million USD -159.481%
ResMed Inc. 1.02 Billion USD 125.466%
Teleflex Incorporated 356.32 Million USD 172.966%
Warby Parker Inc. -63.19 Million USD -311.412%
West Pharmaceutical Services, Inc. 593.4 Million USD 143.815%